SOLUBILITY AND DISSOLUTION ENHANCEMENT OF WATER INSOLUBLE DRUG BY USING DIFFERENT HYDROPHILLIC CARRIERS AND FORMULATED INTO TABLET DOSAGE FORM
Rosuvastatin calcium is a BCS class II drug (low solubility and high permeability), used as a lipid lowering agent by acting as HMG CoA reductase inhibitor and it is used for the management of hyperlipidemia. Increase in the solubility of the poorly water soluble drug is the most challenging aspect for various new chemical entities which leads to the unsatisfactory dissolution profile, consequently, the bioavailability. There are various techniques to enhance the solubility of the drug, such as particle size reduction, nanosuspension, use of surfactants, salt formation, pH modifier, solid dispersion etc. Solid dispersions in water-soluble carriers have attracted considerable interest as a means of improving the dissolution rate and hence possibly bioavailability, of a range of hydrophobic drugs. Carriers are the major players in these formulations, e.g., hydroxypropylmethylcellulose, ethyl cellulose, methyl cellulose, polyvinyl pyrrolidone, polyvinyl alcohol etc. HPMC and EC is one of the most efficient polymers among all of these to work as a carrier for these drugs to enhance solubility. Four ratios of drug: carrier were prepared (1:1, 1:3, 1:5, 1:7) and 1:7 was the optimized ratio which shows a maximum release of the drug via dissolution profile. In the present work, Solid Dispersions were prepared by Kneading technique to enhance the solubility of Rosuvastatin Calcium. Solid dispersions were evaluated for Fourier transform infrared spectroscopy (FTIR), thermal analysis, dissolution studies, powder X-ray diffraction (PXRD), scanning electron microscopy (SEM), and stability studies to confirm enhancement in solubility. The prepared solid dispersions are formulated into tablet dosage form and characterized by various parameters i.e. weight variation, hardness, friability, disintegration, and dissolution rate. The evaluated parameters of tablet dosage form show increase in solubility and dissolution rate of the pure drug.
Keywords: Rosuvastatin Calcium, Carriers, HPMC, EC, Solid Dispersion Tablet
2. Brahmankar D.M, Jaiswal S.B. Biopharmaceutics And Pharmacokinetics A Treatise. Vallabh Prakashan 2009;First Edition (1995):5-37
3. Sanghai B, Aggarwal G, HariKumar SL, Solid self microemulsifying drug deliviry system: a review, Journal of Drug Delivery and Therapeutics, 2013; 3(3):168-174
4. Chaulang G, Patel P, Hardikar S, Kelkar M, Bhosale A, Bhise S. Formulation and evaluation of Solid Dispersion of furosemide in Sodium Starch Glucolate. Trop J Pharma 2009; Vol.8(1): 43-51
5. Dabbagh M.A, Taghipour B.Investigation of Solid Dispersion technique in Characterstics of Ibuprofen Powder. IJPS 2007; Vol.3(2):69-76
6. Khan AD, Singh L, Various techniques of bioavailability enhancement: a review, Journal of Drug Delivery and Therapeutics, 2016; 6(3):34-41
7. Lakade S.H, Bhalekar M.R. Different types of method for modified dosage form for Enhancement of Dissolution Rate through Solid Dispersion. IJPSR 2010;Vol I: 54-60
8. Mundhe AV, Cocrystalization: an alternative approach for solid modification, Journal of Drug Delivery and Therapeutics, 2013; 3(4):166-172
9. Rodde M.S, Divase G.T, Devkar T.B, Tikade A.R. Solubility and Bioavailability Enhancement of Poorly Aqueous Soluble Atorvastatin: In Vitro, Ex Vivo, and In Vivo Studies. Bio Med Research International;Vol 2014: Pages 10
10. Dalvi PB, Gerange AB, Ingale PR, Solid dispersion: strategy to enhance solubility, Journal of Drug Delivery and Therapeutics, 2015; 5(2):20-28
11. Alagar R.M, Rao K.N.V, Anil T, Banji D, Kumar M S, Kumar S.D. Simultaneous Estimation of Rosuvastatin Calcium and Ezetamibe in Tablet Dosage form by RP-HPLC. IJRPB 2014; Vol.2(5):1378
12. Amidon G.L, Lennernas H, Shah V. P, Crison, J. R, Theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res; Vol.12(3): 413-420.
13. Serajuddin A. T. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci; 1999 :1058â€“1066
14. Van den M. G. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm.Sci; Vol. 12: 261â€“269.
15. Nayak A. K. Current developments in Orally disintegrating tablet technology. Journal of pharmaceutical education research 2011; 21-34.
16. Natarajan R, Komala G, Ramcy TC, Mohan S. Dissolution Enhancement Of Aceclofenac Solid Dispersion Prepared With Hydrophilic Carriers By Solvent Evaporation Method. International Journal Of Research In Pharmacy And Chemistry 2014; Vol 4(1): 83-89
17. Sathali A.A.H, Jayalakshmi J. Enhancement Of Solubility And Dissolution Rate Of Olmesartan Medoxomil By Solid Dispersion Technique.J. Curr. Chem. Pharm. Sci;Vol 3(2), 2013:123-134
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).